Alphatec Holdings, Inc. ATEC
We take great care to ensure that the data presented and summarized in this overview for Alphatec Holdings, Inc. is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Top Institutions Holding ATEC
View all-
Black Rock Inc. New York, NY8.29MShares$137 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.66MShares$110 Million0.0% of portfolio
-
American Century Companies Inc Kansas City, MO6.18MShares$102 Million0.04% of portfolio
-
Royal Bank Of Canada Toronto, A64.45MShares$73.7 Million0.01% of portfolio
-
Bnp Paribas Asset Management Holding S.A.4.01MShares$66.3 Million0.11% of portfolio
-
Braidwell LP Stamford, CT3.64MShares$60.2 Million2.47% of portfolio
-
Bank Of America Corp Charlotte, NC2.79MShares$46.2 Million0.0% of portfolio
-
State Street Corp Boston, MA2.76MShares$45.7 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA2.7MShares$44.6 Million0.0% of portfolio
-
Nuveen Asset Management, LLC Chicago, IL2.58MShares$42.8 Million0.01% of portfolio
Latest Institutional Activity in ATEC
Top Purchases
Top Sells
About ATEC
Alphatec Holdings, Inc., a medical technology company, designs, develops, and advances technologies for the surgical treatment of spinal disorders. The company offers SafeOp Neural InformatiX System, an Alpha InformatiX product platform designed to reduce the risk of intraoperative nerve injury; Sigma transforaminal lumbar interbody fusion pedicle-based access system that provides direct visualization of anatomical landmarks; Sigma PTP Access and Patient Positioning System; squadron lateral retractor designed to maximize patient outcomes; Invictus Spinal Fixation System, a thoracolumbar fixation system to treat a range of pathologies; and Invictus MIS SingleStep System that provides minimally invasive pedicle screw placement. It also provides Invictus Modular Fixation Systems designed to increase adaptability with the power of screw modularity; OsseoScrew system to restore the integrity of the spinal column; Arsenal spinal fixation system, a comprehensive thoracolumbar fixation platform to fix a range of degenerative to deformity pathologies and surgical procedures; Aspida Anterior Lumbar Plating System, a fixation system for anterior lumbar interbody fusion; AMP Anti-Migration Plate; OCT Spinal Fixation System; trestle luxe anterior cervical plate system; and Insignia Anterior Cervical Plate System. In addition, the company offers IdentiTi Porous Ti, Transcend Lateral, and Battalion Posterior Interbody Implants; and biologics consisting of Cervical Structural Allograft Spacers, 3D ProFuse Demineralized Bone Scaffold, Neocore Osteoconductive Matrix, Alphagraft Demineralized and Cellular Bone Matrix, and Amnioshield Amniotic Tissue Barrier, as well as EOS imaging products. It sells its products through a network of independent distributors and direct sales representatives in the United States. The company was founded in 1990 and is headquartered in Carlsbad, California.
Insider Transactions at ATEC
Insider Transaction List
View allDate | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Sep 02
2025
|
Patrick Miles CEO |
SELL
Open market or private sale
|
Direct |
300,000
-5.12%
|
$4,500,000
$15.73 P/Share
|
Aug 21
2025
|
Scott Lish CHIEF OPERATING OFFICER |
SELL
Open market or private sale
|
Direct |
6,323
-0.95%
|
$101,168
$16.01 P/Share
|
Aug 14
2025
|
Patrick Miles CEO |
SELL
Bona fide gift
|
Direct |
10,000
-0.17%
|
-
|
Aug 13
2025
|
Scott Lish CHIEF OPERATING OFFICER |
SELL
Open market or private sale
|
Direct |
9,302
-1.38%
|
$148,832
$16.0 P/Share
|
Aug 06
2025
|
Craig E Hunsaker EVP, PEOPLE & CULTURE |
SELL
Open market or private sale
|
Direct |
10,876
-0.78%
|
$163,140
$15.33 P/Share
|
Aug 06
2025
|
John Todd Koning CHIEF FINANCIAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
5,315
-1.14%
|
$79,725
$15.34 P/Share
|
Aug 06
2025
|
David Sponsel EVP, SALES |
SELL
Payment of exercise price or tax liability
|
Direct |
982
-0.15%
|
$14,730
$15.34 P/Share
|
Aug 05
2025
|
Craig E Hunsaker EVP, PEOPLE & CULTURE |
SELL
Open market or private sale
|
Direct |
50,000
-3.45%
|
$750,000
$15.0 P/Share
|
Aug 05
2025
|
Tyson Eliot Marshall GENERAL COUNSEL & CORP. SEC. |
SELL
Open market or private sale
|
Direct |
18,092
-2.0%
|
$253,288
$14.91 P/Share
|
Aug 05
2025
|
Scott Lish CHIEF OPERATING OFFICER |
SELL
Open market or private sale
|
Direct |
16,666
-2.41%
|
$249,990
$15.0 P/Share
|
Aug 04
2025
|
Scott Lish CHIEF OPERATING OFFICER |
SELL
Open market or private sale
|
Direct |
17,857
-2.52%
|
$249,998
$14.0 P/Share
|
Aug 01
2025
|
Tyson Eliot Marshall GENERAL COUNSEL & CORP. SEC. |
SELL
Open market or private sale
|
Direct |
12,878
-2.74%
|
$154,536
$12.0 P/Share
|
Aug 01
2025
|
Scott Lish CHIEF OPERATING OFFICER |
SELL
Open market or private sale
|
Direct |
36,081
-4.84%
|
$432,972
$12.53 P/Share
|
Jul 10
2025
|
Scott Lish CHIEF OPERATING OFFICER |
SELL
Open market or private sale
|
Direct |
3,982
-0.53%
|
$47,784
$12.0 P/Share
|
Jul 10
2025
|
Tyson Eliot Marshall GENERAL COUNSEL & CORP. SEC. |
SELL
Open market or private sale
|
Direct |
1,500
-0.32%
|
$18,000
$12.0 P/Share
|
Jun 13
2025
|
Scott Lish CHIEF OPERATING OFFICER |
SELL
Open market or private sale
|
Direct |
22,727
-2.95%
|
$249,997
$11.07 P/Share
|
Jun 11
2025
|
Mortimer Berkowitz Iii |
BUY
Grant, award, or other acquisition
|
Direct |
15,131
+2.18%
|
-
|
Jun 11
2025
|
Quentin S. Blackford |
BUY
Grant, award, or other acquisition
|
Direct |
15,131
+2.59%
|
-
|
Jun 11
2025
|
David M Demski |
BUY
Grant, award, or other acquisition
|
Direct |
15,131
+3.4%
|
-
|
Jun 11
2025
|
David R Pelizzon |
BUY
Grant, award, or other acquisition
|
Direct |
15,131
+4.18%
|
-
|
Last 12 Months Summary
Grant, award, or other acquisition | 2.48M shares |
---|---|
Exercise of conversion of derivative security | 111K shares |
Bona fide gift | 46.1K shares |
---|---|
Payment of exercise price or tax liability | 220K shares |
Open market or private sale | 1.61M shares |